Clinical Trial Update: Clinical Trial of 4% Niacinamide Versus 0.05% Desonide for the Treatment of Axillar Hyperpigmentation [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing 4% niacinamide with 0.05% desonide for axillary hyperpigmentation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperpigmentation

Drugs mentioned

• Desonide 0.05% (desonide)
• Niacinamide 4% (niacinamide)

Snippet

Sponsor: Universidad Autonoma de San Luis Potosí | Conditions: Hyperpigmentation | Phase 4 | Status: COMPLETED